BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6167819)

  • 1. Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):896-905. PubMed ID: 6167819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of intravenous prenalterol in severe heart failure.
    Kirlin PC; Pitt B
    Am J Cardiol; 1981 Mar; 47(3):670-5. PubMed ID: 7468501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous prenalterol in acute and chronic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
    J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE; Bohn I; Hahn B; Kment A; Motz U
    J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF; Ireland MA; Littler WA
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
    Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
    Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
    G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
    J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dobutamine infusion in conscious dogs with and without acute myocardial infarction. Effects on systemic hemodynamics, myocardial blood flow, and infarct size.
    Liang CS; Yi JM; Sherman LG; Black J; Gavras H; Hood WB
    Circ Res; 1981 Jul; 49(1):170-80. PubMed ID: 7237692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
    Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
    Vik-Mo H; Yasay G; Maroko PR; Ribeiro LG
    J Cardiovasc Pharmacol; 1985; 7(4):784-90. PubMed ID: 2410722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
    Kirlin PC; Romson JL; Pitt B; Lucchesi B
    Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.